IMV

-$0.0013 (-0.18%) As of 4:20 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell IMV and other ETFs, options, and stocks.

About IMV

IMV, Inc. is a clinical-stage biopharmaceutical company, which engaged in providing a novel class of cancer immunotherapies and vaccines against infectious diseases including COVID-19. The firm leverages its delivery platform (DPX) that programs immune cells directly within the human body to produce robust and sustained target killing capabilities.

CEO
Andrew Hall
Employees
97
Headquarters
Dartmouth, Nova Scotia
Founded
2007

IMV Key Statistics

Market cap
58.61M
Price-Earnings ratio
—
Dividend yield
—
Average volume
95.46K
High today
$0.7293
Low today
$0.69
Open price
$0.71
Volume
54.82K
52 Week high
$2.41
52 Week low
$0.5621

IMV Earnings

-$0.14
-$0.09
-$0.05
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 10, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure